Frontlight ResearchEarly access
CompletedNo phase
Using EMR Data and AI to Develop a Passive Digital Marker to Predict Postoperative Delirium
Key facts
- Who runs it
- Indiana University
- Where
- Indianapolis, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 60 people enrolled
- Started
- 23 Jul 2024
- Ended
- 21 Aug 2026
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- PDM Alert
- Record updated
- 22 October 2026
Who can take part
- Age
- 65 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- 65 years old Planned inpatient major surgery requiring inpatient stay ≥ 1 day
Who cannot take part
- Alcohol or drug withdrawal
- Baseline cognitive impairment or a diagnosis of Alzheimer's Disease/Alzheimer's Disease and Related Dementias (AD/ADRD)
- Prisoner status
- Unable to communicate with research staff due to sensory impairments
- Not fluent in English
- Currently has a personal safety attendant
Where in United States
- Indiana University Health University HospitalIndianapolis, United States
About the trial
What the trial wants to find out
This study will be a pilot randomized controlled trial that will determine the effect of an indicator of delirium risk, which will be delivered either via a paper form or via the electronic medical record, on (1)postoperative delirium incidence; and (2)the development of long term cognitive decline and dementia.
The 2 groups in the trial
- No PDM AlertPlacebo, for comparison
No PDM alert will be placed on subject's record
Treatment: PDM Alert
- PDM AlertTreatment being tested
PDM alert will be placed on subject's record
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 22 October 2026